Search results
Results from the WOW.Com Content Network
The Functional Capacity Index (FCI) is a measure of a person's level of function for the following 12 months after sustaining some form of illness or injury. [1] The FCI incorporates ten physical functions and gives each a numerical value on a scale of 0 to 100, with 100 representing no limitations on a person's everyday function.
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials.
The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure.It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.
Furthermore, it aims to allow clinicians to track changes in the functional status of patients from the onset of rehab care through discharge and follow-up. The FIM's assessment of degree of disability depends on the patient's score in 18 categories, focusing on motor and cognitive function. Each category or item is rated on a 7-point scale (1 ...
IHSS may refer to: Honduran Social Security Institute (Instituto Hondureño de Seguridad Social in Spanish), social security in Honduras Idiopathic hypertrophic subaortic stenosis , an older term for hypertrophic obstructive cardiomyopathy (HOCM)
The Barthel index signifies one of the first contributions to the functional status literature and it represents occupational therapists' lengthy period of inclusion of functional mobility and ADL measurement within their scope of practice. [1] The scale is regarded as reliable, although its use in clinical trials in stroke medicine is ...
The Duke Activity Status Index (DASI) is an assessment tool used to evaluate the functional capacity of patients with cardiovascular disease (CVD), such as coronary artery disease, myocardial infarction, and heart failure. [1] In clinical practice, DASI can be used to assess the effects of medical treatments and cardiac rehabilitation as well. [2]
Currently, about 50–60% of people with a high index of clinical suspicion for HCM will have a mutation identified in at least one of nine sarcomeric genes. Approximately 40% of these mutations occur in the β-myosin heavy chain gene on chromosome 14 q11.2-3, and approximately 40% involve the cardiac myosin-binding protein C gene.